First Pass

136 stories from 17 sources

The week in Medicine and Healthcare

Congo Ebola Outbreak Escapes Containment

November 2026
123456789101112131415161718192021222324252627282930

Week’s Recap

The week's health story was defined by worsening infectious-disease control, widening coverage disputes, and promising technologies that still require proof before they can safely guide care.

Click on a headline to see stories that shaped it.

Threads

Stories that evolved over the week.

8 threads

Defined the week

Ebola Response Splinters Across Outbreaks

Congo's Ebola outbreak expanded and remained uncontrolled as conflict, weak health systems, funding gaps, and mistrust blocked vaccination, treatment, and surveillance. Kenya and Nigeria moved toward outbreak clearance, showing that containment progress remained uneven across the region.

10 stories, Nov 10 to 15
Defined the week

Measles Loses Ground in US and Americas

A formal review put U.S. measles-elimination status at risk as transmission continued, while a New York outbreak caused a death. The U.S. death toll then reached ten, turning resurgence into a sustained national threat.

5 stories, Nov 11 to 13
Major

AI Moves From Administration Toward Care

Healthcare AI expanded from hospital operations and wearable monitoring into clinical prediction, patient-facing tools, and automated administrative work. The week's developments also kept accuracy, oversight, and the limits of generated advice at the center of adoption decisions.

14 stories, all week
Major

Coverage Politics Pull in Opposite Directions

States and lawmakers advanced proposals to broaden public coverage, including Medicaid expansion and lower Medicare eligibility, while Medicaid work-rule delays and a rushed rollout exposed risks of coverage loss. The result was a widening split between expansion plans and tighter access conditions.

6 stories, all week
Major

GLP-1s Gain Uses as Safety Questions Grow

GLP-1 drugs gained a formal warning for rare vision loss while developers pursued new uses in sleep apnea and oral treatment. Evidence on pregnancy exposure remained unsettled, adding another uncertainty to an expanding drug class.

9 stories, Nov 9 to 13
Major

Conflict Makes Healthcare Blind and Inaccessible

Attacks, detentions, and supply restrictions further dismantled care in Gaza, while siege conditions in Taiz weakened disease reporting and surveillance. Across both settings, conflict blocked treatment and created blind spots that can allow illness to spread.

3 stories, Nov 12 to 14
Notable

Alzheimer's Detection Expands Beyond Memory

Research broadened Alzheimer's detection beyond conventional hippocampal monitoring, identifying possible signals in other brain regions and in nerve-to-muscle connections. The markers could support earlier screening, but both lines of evidence still require validation in patients.

3 stories, Nov 9 to 14
Notable

Drug Pricing Plans Trigger Industry Workarounds

Proposed most-favored-nations pricing agreements moved toward congressional scrutiny as drugmakers reconsidered launch timing and market access. The emerging workarounds could delay overseas availability and weaken the policy's effect on U.S. costs.

2 stories, Nov 10 to 11